Cocaine update: from bench to bedside.
The aim of this paper is to review and explore the psychopharmacology of cocaine from two divergent points of view--the chronic user and the laboratory. Cocaine's behavioral effects will be correlated with neurophysiological, neurochemical events, and reports by users of consequences of chronic use. These studies and reports when pieced together offer considerable promise in the development of a natural history of compulsive cocaine use. Additional neurochemical and neurophysiological research investigations are needed to allow for the development of non-addicting treatments for detoxification (à la clonidine) and prophylaxis (à la naltrexone). In the absence of these data cocaine treatment programs have been developed borrowing heavily from self help, contingency contracting and inpatient programs for working addicts.
D000339:Affect / Q000187:drug effects; D001364:Awareness / Q000187:drug effects; D001519:Behavior / Q000187:drug effects*; D001921:Brain / Q000187:drug effects; D003042:Cocaine / Q000494:pharmacology* / Q000506:poisoning; D003702:Delusions / Q000139:chemically induced; D004298:Dopamine / Q000378:metabolism; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D008959:Models, Neurological; D009638:Norepinephrine / Q000378:metabolism; D010900:Pituitary Diseases / Q000139:chemically induced; D012677:Sensation / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D013312:Stress, Physiological; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000628:therapy; D013569:Synapses / Q000378:metabolism; D013959:Thyroid Diseases / Q000139:chemically induced
D012701:Serotonin; D003042:Cocaine; D004298:Dopamine; D009638:Norepinephrine